ABSTRACT
INTRODUCTION
Small peptides and peptidelike drugs are often too polar to cross lipid bilayers by simple diffusion. Therefore, translocation across membranes depends on transport by a suitable carrier, and orally administered peptoid drugs would be poorly absorbed unless transported (1). The main intestinal H + /dipeptide transporter protein, PepT1, is thought to play a critical role in oral bioavailability of peptidelike drugs (2) (3) (4) (5) (6) (7) . hPepT1 is a member of a well defined small gene family, the proton-dependent oligopeptide transporters (POT, also referred to as PTR), with ancestral roots that can be traced to bacterial, fungal, and plant peptide transporters (8) (9) (10) (11) . This class of secondary active transporters has broad selectivity for di-and tripeptides, whereas ability to transport longer peptides decreases drastically with increasing length. Most of the POT members share a common structural architecture with ~12 predicted transmembrane domains (TMDs), but among the dipeptide transporters in distant phyla, variations on this theme do occur. We have confirmed the transmembrane topology of at least a portion of the main intestinal transporter, hPepT1, using an epitope tagging approach (12) .
Until recently, only two POT genes had been identified in mammalian species, PepT1 and PepT2, the main renal peptide transporters (6, 13) . cDNA's of the respective human orthologues have been cloned (orthologue refers to the same gene in different species) (13, 14) . These transporters display overlapping, broad substrate selectivity and interact with numerous drugs, some with chemical structures quite distinct from peptides. Substrates include important drug classes, such as β-lactam and cephalosporin antibiotics, renin inhibitors, ACE inhibitors, and 5'-nucleoside esters of amino acids, such as valcyclovir (15) .
With a few exceptions, single amino acids are not substrates. In 1997, a third cDNA was cloned, encoding the rat peptide-histidine transporter, rPHT1 (16) , with use of sequence alignments of POT members with the expressed sequence tags (EST) database. Currently cloned mammalian POT cDNAs and deduced proteins are summarized in Table 1 .
Whereas rPHT1 is mainly expressed in rat brain and retina, the identity and tissue distribution of its human orthologue remain unknown. We have found numerous human ESTs that on the basis of high sequence identity among them appear to represent the human orthologue of the rat transporter gene rPHT1. Many of these ESTs were isolated from tissues other than brain, eg, human colon carcinoma, suggesting that the tissue distribution of this gene product in humans might differ from that in rat. This finding cautions against assuming that only one H + /dipeptide transporter is expressed in a tissue of interest. Nakanishi et al (1997) have postulated the presence of a distinct peptide carrier in a human fibrosarcoma cell line (17) . To understand peptide transport, all relevant genes need to be identified and characterized. Comprehensive sequence analysis reveals the presence of at least five possible members of the POT family in C elegans (this report). Therefore, one would expect several POT genes to exist in the human genome, in addition to hPepT1 and hPepT2. Because the POT family shares limited sequence similarity with other transporter families, any newly identified sequences with significant similarity to POT proteins are likely to be members of the POT family. Therefore, our overall objective was to identify all human homologues of the POT family and determine their tissue distribution. In this study, we show results obtained from a bioinformatics analysis of the available databases, supplemented by assays of gene expression in human tissues.
To find all members of a gene family, we have developed a Java-based program, which iteratively searches sequence databases for homologous genes using BLAST. Called INCA (iterative neighborhood cluster analysis; http://itsa.ucsf.edu/~gram/home/inca/), this program identifies a complete cluster of sequence neighbors in the database (18) . By applying INCA to search the nonredundant protein sequence database and subsequently the human EST database for novel dipeptide transporters, we have identified two new human genes as possible members of POT and several ESTs representing candidate genes of additional human peptide transporters of the POT family. A greater repertoire of the dipeptide transporter gene family in humans must be considered in the interpretation of pharmacological studies with peptoid drugs and could also serve for targeting drugs to specific tissues. Moreover, sequence variations in these transporters could account for interindividual genetic differences in the disposition of peptoid drugs.
METHODS

Iterative Neighborhood Cluster Analysis (INCA) using BLAST
Scanning available databases for all genes and proteins related to each other requires multiple BLAST runs (basic local alignment search tool; http://www.ncbi.nlm.nih.gov/BLAST/). Each individual run within an INCA analysis used gapped BLAST of the v2.0.9 family of programs (19) . With gapped BLAST, we found local alignments of similar sequence fragments while allowing for gaps in the alignment. This approach enhances detection of sequence similarities and exceeds nongapped BLAST searches. We have developed an iterative BLAST search termed INCA (http://itsa.ucsf.edu/~gram/home/inca/) (18) , which automatically performs BLAST on all sequences identified in the first run with a maximal Expect value (10 -6 in the present study). In subsequent runs, INCA further tabulates any newly identified sequences scoring with E < 10 -6 , until no further sequences are found. The Expect value estimates the probability that a given alignment score describing sequence similarity could have arisen by chance in the database searched. E = 10 -6 is often taken as a cutoff below which homology is considered possible while 10 -9 indicates probable homology (cutoff E values may change as a function of the type of protein and the analysis used). The INCA results are tabulated so that sequences found in subsequent runs are listed with the sequence in the first run yielding the lowest E value (highest similarity). Thus, a first pass with multiple iterative BLASTs identifies all known protein sequences belonging to the POT family, regardless of the starter sequence. In a second pass, we used this entire neighborhood cluster, performing BLAST with each sequence, to scan the human EST database (BLAST, database: 'human ests'). EST clones represent individual mRNA species extracted from target tissues and converted to cDNAs that are then subcloned and partially sequenced. Upon completion of the second INCA pass, the program tabulates the results with each EST assigned to the protein sequence giving the lowest E value. Thereby, INCA provides a simple and exhaustive means of finding all relevant ESTs and assigning them to their most closely related protein sequence in the core cluster of POT sequences. This facilitates the search for new genes that might be represented by ESTs in the accessible databases.
Sequence Analysis
Sequence analysis programs used are available at http://www.sacs.ucsf.edu/.
Database homology searches were carried out using the NCBI BLAST v2.0.9 family of programs (19) . Contigs of EST sequences (the term contig as used here refers to a contiguous sequence assembled from several overlapping sequence fragments) were assembled using CAP3 (20) and viewed and edited using Sequencher3.0 (www.genecodes.com). The structure of the hPHT2 gene was characterized with FGENESH (Genefinder: A.A. Salamov and V.V. Solovyev, unpublished data, 1999). Multiple alignments of protein sequences were produced with the Pileup GCGv10 (Wisconsin Package Version 10.0; Genetics Computer Group (GCG), Madison, WI), using oldpep matrix with default parameters. Hydropathy plots were generated using Kyte and Doolittle hydropathy measure (21) 
Northern Blot Analysis of hPHT1 and hPHT2 Expression in Human Tissues
Membrane blots containing size-fractionated poly(A)+ mRNA from 12 tissues of human origin were purchased from CLONTECH Laboratories. The accession codes of the ESTs used as probes are W53019 and AA242853 for hPHT1 and hPHT2, respectively. These cDNA's were labeled with α-32 PdATP (3000 Ci/mmol; Amersham, Piscataway, NJ) according to the random priming method, using a kStrip-EZ DNA kit (Ambion, Austin, TX). Hybridization was performed at 42°C overnight after purifying 32 -P-cDNA on a Sephadex G-50 spin column (mini Quick Spin Columns; Boehringer Mannheim, Indianapolis, IN). The blots were washed twice at 42°C for 5 min with low stringency solution (Ambion) and for 15 min with high stringency solution (Ambion). The membranes were exposed against x-ray film at -80°C for 3 to 7 days with intensifying screens. The hybridized probe was removed from the membranes by using a Strip-EZ DNA kit (Ambion) before rehybridization.
RESULTS
Iterative Neighborhood Cluster Analysis (INCA) of the POT Family, First Pass: Nonredundant Protein Databases
Regular BLAST analysis of the protein databases confirmed the presence of three mammalian members reported to belong to the POT family: PepT1, PepT2, and rPHT1. To compile the entire POT family, we then ran INCA with hPepT1 as starter sequence (any sequence is suitable as INCA yields the same sequence cluster regardless of the starter sequence). As shown in Table 2 , there are 68 members of the core cluster of POT sequences (as of November 99), each connected to at least one other core sequence with E = 10 -6 or lower. In the first iteration, 63 sequences were identified by BLAST as possible/probable homologues of hPepT1, while in the second iteration 5 additional sequences appeared in the core cluster of POT. (18) . The protein sequence of hPepT1 served as the starter sequence for pass 1 searching the nr protein databases, and two iterations were done. The core cluster contains all sequences scoring with Expect values E < 10-6. These are numbered 1-63, or with a second number to indicate the ranking order of a newly added sequence in iteration 2 (eg, 42.41). Underlining indicates human core sequences; bold-face indicates multi-drug efflux transporter in POT core cluster; bold-face with italics indicates putative C elegans transporters. In pass 2, each of the 68 members of the core cluster was run against the human EST database, and the results tabulated such that the identified ESTs were listed with the core sequence providing the highest score. Note the inclusion of a bacterial drug-resistance transporter in the protein core cluster (bold-face); this sequence would have identified more members of the core cluster in a third iteration (not done here). These include bacterial drug resistance transporters which are currently listed outside the core cluster. Putative POT members from C elegans are shown in bold-face with italics. Further, note that the human ESTs mainly cluster with sequences 11 (hPepT2), 50 (rPHT), and 51 (mouse cAMPinducible 1 protein). 
Relationship of POT Family to Other Transporters
Earlier INCA runs had yielded similar results but with fewer sequences in the core cluster. The same analysis performed a year earlier revealed only 46 core sequences and converged after two iterations; that is, further iterations did not reveal any new sequences scoring with E < 10 -6 . This had suggested that the POT family shows rather unique sequence characteristics, with no sequence from other transporter families scoring with E = 10 -6 or lower.
However, continued deposition of new sequences has enlarged the POT family and general databases considerably. This could result in the discovery of links to other transporter families possibly related to POT in evolution. Indeed, the recent INCA run shown in Table 2 identified a distinct sequence with E < 10 -6 belonging to the family of bacterial drug resistance transporters, a multidrug-efflux transporter of Campylobacter (Table 2 , core cluster; bold-face type). To avoid including numerous multidrug-efflux transporters with the POT core family in a third iteration of BLAST, Table 2 contains only two iterations. A number of these drug-resistance transporters of the major facilitator type transporter family appear in the list of neighbor sequences outside the core cluster ( (24)). These results support the supposition that the peptide transporter family POT is indeed related in evolution to other transporter families. We will pursue these relationships to better understand the structure and evolution of the peptide transporter family.
Search for New POT Members
The core cluster contains 5 putative POT genes from the completely sequenced genome of C elegans ( Table 2 , bold-face and italics). Each of these deduced proteins has high similarity to hPepT1. This finding suggests that the human genome may also contain more POT members than are currently cloned. Table 2 includes a number of deposited sequences encoding the main intestinal and renal transporters, hPepT1 (sequences 1-3) and hPepT2 (sequence 12), and their orthologues in other mammalian species. The pH sensing regulatory factor of peptide transporter (sequence 20) (25) appears to represent a possible truncated splice isoform of hPepT1. Also shown in the core cluster of Table 2 , the rat peptide/histidine transporter (rPHT1) (sequence 50; E = 5 × 10 -50 against hPepT1) is adjacent to a new sequence with high similarity to it, namely the mouse cAMP-inducible protein 1 (sequence 51). The latter was recently cloned from a lymphoid cell line and had not been suspected to belong to the POT family (26) . We will demonstrate below that both rPHT1 and mouse cAMP-inducible 1 protein have apparent human orthologues, which we will term hPHT1 and hPHT2, respectively. This suggests that rPHT1 and mouse cAMP-inducible 1 protein represent two distinct but closely related genes belonging to the POT family.
The core cluster of POT sequences contains one additional human sequence, namely, erythroid differentiation-related factor 2 (sequence 42.41, Table 2 ). The E value (4 × 10 -9 ) suggests probable homology to a putative POT transporter of Bacillus subtilis (sequence 42; 13 predicted TMDs). However, this sequence is rather short (107 residues), showing good sequence similarity with TMD11 and adjacent loop of the B subtilis transporter. More studies are needed to discover the biological relevance of this finding.
In summary, the INCA analysis of the protein sequence databases revealed the presence of 4 mammalian sequences as probable members of POT: PepT1, PepT2, PHT1, and cAMP-inducible 1 protein (the latter two termed PHT1 and PHT2 in our nomenclature).
Second Pass INCA: Scanning the Human EST Database
All 68 sequences in the core cluster (Table 2) ), sorted by highest similarity to one of the 68 core protein sequences, is also included with Table 2 . Curiously, no EST scored best with PepT1, presumed to be the main intestinal transporter in rodents and, by inference, in humans (intestinal ESTs may be underrepresented in the available EST databases). Further, seven ESTs assorted with the cloned human hPepT2; however, it remains to be seen whether all seven are indeed representatives of hPepT2. With E scores exceeding 10 -10 , it is possible that these ESTs with moderate similarity could represent distinct genes or splice variants (not analyzed further). Numerous human ESTs scored best with the rat peptide histidine transporter, rPHT (sequence 50), and with mouse cAMP-inducible 1 protein (sequence 51). We therefore assembled these ESTs into contiguous sequences to identify the respective human orthologous gene products, termed hPHT1 and hPHT2.
In the human EST core cluster (Table 2) , two single ESTs scored best with putative peptide transporters from bacteria (sequences 42 and 48 of the core proteins of POT). Additional analysis will be required to ascertain whether the respective human genes suggested by these two ESTs could represent yet additional members of the human POT gene family.
hPHT1 and hPHT2 Sequences Assembled from Human ESTs
Scanning the human EST database, we have identified numerous ESTs that appear to represent the human orthologues of rPHT and cAMP-inducible 1 protein. Table 3 lists the ESTs firmly assigned to the presumed human orthologue of rPHT1 (hPHT1) and of cAMP-inducible 1 protein (termed here hPHT2) (cutoff E value ~10 -20 ). For comparison, Table 3 also displays the ESTs assigned to hPepT2, whereas no ESTs appeared to represent hPepT1. The tissue source of the numerous ESTs representing hPHT1 is of considerable interest because in the rat, rPHT expression is largely confined to the brain and retina. Yet, the hPHT1-related ESTs derive from many body tissues, including colon carcinoma. This raises the possibility that hPHT1 is broadly expressed in many human tissues. Approximately 50 ESTs served to assemble a contig DNA sequence of the presumed hPHT1 nucleotide sequence Figure 1A and Figure 1B ; Table 4 ). A schematics of the hPHT1 contig assembly Figure 1A contains the minimum number of EST's spanning the length of the deduced hPHT1 sequence. To view the EST coverage of each segment, click on the EST/region of interest. This will reveal segments with numerous overlapping ESTs. Because multiple ESTs cover the same regions of hPHT1, one can deduce possible sequence variations in the human population where EST sequences are not identical. Clearly, many of these variations may be due to sequencing errors, but in a few cases a variation occurs more than once at the same location. These variations increase the probability that a genetic variant might be involved. The contig sequence is closely related to that of rPHT1; however, the first ~50 5'-terminal base pairs are missing. (It appears that there is a rare NotI site at the 5'-end, which could have caused truncation during preparation for EST sequence analysis.) Thus, the EST contig is likely to represent >95% of the coding region of hPHT1. The deduced hPHT1 amino acid sequence is shown in Table 4 . CCTCGCGGTGCGCGGGGCCCTCGACGGTGGCGGCGGGCGGCGGGCGCGGCCGTGCTGCTG  GTGGAGATGCTGGAGCGCGCCGCCTTCTTCGGCGTCACCGCCAACCTCGTGCTGTACCTC  AACAGCACCAACTTCAACTGGACCGGCGAGCAGGCGACGCGCGCCGCGCTGGTATTCCTG  GGCGCCTCCTACCTGCTGGCGCCCGTGGGCGGCTGGCTGGCCGACGTGTACCTGGGCCGC  TACCGCGCGGTCGCGCTCAGCCTGCTGCTCTACCTGGCCGCCTCGGGCCTGCTGCCCGCC  ACCGCCTTCCCCGACGGCCGCAGCTCCTTCTGCGGAGAGATGCCCGCGTCGCCGCTGGGA  CCTGCCTGCCCCTCGGCCGGCTGCCCGCGCTCCTCGCCCAGCCCCTACTGCGCGCCCGTC  CTCTACGCGGGCCTGCTGCTACTCGGCCTGGCCGCCAGCTCCGTCCGGAGCAACCTCACC  TCCTTCGGTGCCGACCAGGTGATGGATCTCGGCCGCGACGCCACCCGCCGCTTCTTCAAC  TGGTTTTACTGGAGCATCAACCTGGGTGCTGTGCTGTCGCTGCTGGTGGTGGCGTTTATT  CAGCAGAACATCAGCTTCCTGCTGGGCTACAGCATCCCTGTGGGCTGTGTGGGCCTGGCA  TTTTTCATCTTCCTCTTTGCCACCCCCGTCTTCATCACCAAGCCCCCGATGGGCAGCCAA  GTGTCCTCTATGCTTAAGCTCGCTCTCCAAAACTGCTGCCCCCAGCTGTGGCAACGACAC  TCGGCCGACCGTCAATGTGCCCGCGTGCTGGCCGACGAGAGGTCTCCCCAGCCAGGGGCT  TCCCCGCAAGAGGACATCGCCAACTTCCAGGTGCTGGTGAAGATCTTGCCCGTCATGGTG  ACCCTGGTGCCCTACTGGATGGTCTACTTCCAGATGCAGTCCACCTATGTCCTGCAGGGT  CTTCACCTCCACATCCCAAACATTTTCCCAGCCAACCCGGCCAACATCTCTGTGGCCCTG  AGAGCCCAGGGCAGCAGCTACACGATCCCGGAAGCCTGGCTCCTCCTGGCCAATGTTGTG  GTGGTGCTGATTCTGGTCCCTCTGAAGGACCGCTTGATCGACCCTTTACTGCTGCGGTGC  AAGCTGCTTCCCTCTGCTCTGCAGAAGATGGCGCTGGGGATGTTCTTTGGTTTTACCTCC GTCATTGTGGCAGTCCTGGAGATGGAGCGCTTACACTACATCCACCACAACGAGACCGTG  TCCCAGCAGATTGGGGAGGTCCTGTACAACGCGGCACCACTGTCCATCTGGTGGCAGATC  CCTCAGTACCTGCTCATTGGGATCAGTGAGATCTTTGCCAGCATCCCACTGGAGTTTGCC  TACTCAGAGGCCCCGCGCTCCATGCAGGGCGCCATCATGGGCATCTTCTTCTGCCTGTCG  GGGGTGGGCTCACTGTTGGGCTCCAGCCTAGTGGCACTGCTGTCCTTGCCCGGGGGCTGG  CTGCACTGCCCCAAGGACTTTGGGAACATCAACAATTGCCGGATGGACCTCTACTTCTTC 
Putative Splice Variants of hPHT1
Several ESTs appear to span a sequence insert, suggesting the presence of possible splice variants shown in Figure 1B . Several variant ESTs assemble into a contig sequence containing an additional coding region of ~100 amino acid residues in the predicted extracellular loop between TMDs 11 and 12 (Variant A). It will be interesting to see the functional consequences of this insertion. Yet 3 additional ESTs -; also representing hPHT1 -; assembled into a contig sequence suggestive of a variant form with a somewhat smaller insertion in the same location Figure 1B . Lastly, RT-PCR analysis of several tissues resulted in two bands, both found to be related to hPHT1 upon sequence analysis. The faster migrating band contained a gap of 169 bps in the middle of hPHT1 Figure 1B , Variant B; for RT-PCR results see Figure 5A ). Some of the putative hPHT1 splice variants may introduce a frame shift and would not be expected to result in a functionally active transporter. These variants need to be cloned individually and tested experimentally. The information presented here is therefore important for guiding cloning efforts to produce functional hPHT1 protein.
Genomic hPHT2 Sequence.
The human EST contig sequence corresponding to rat cAMP-inducible 1 protein served to scan the human nr nucleotide databases. This revealed a PAC clone (P1-derived artificial chromosome) containing human genomic sequences closely related to the mouse cDNA-encoding cAMP-inducible 1 protein.
Using the cDNA sequence of cAMP-inducible 1 protein, we were able to identify the likely introns and exons representing the presumed hPHT2 gene Figure 2 ; click on the introns and exons to display DNA sequence). Each of the intron-exon boundaries are flanked by GT. . . AG in the intron sequence. Thus, the intron structure follows the GT-AG rule, where GT is called the splice donor and AT is called the splice acceptor.
Figure 2. Predicted hPHT2 gene structure (A). Click on the introns and exons to view genomic sequence
The deduced cDNA coding sequence and protein sequence are shown in Table 4 . Table 5 lists the identities and similarities among the protein sequences of the main mammalian members of the POT family. While hPepT1 and hPEPT2 represent one branch of this family, hPHT1, hPHT2, rPHT, and mouse cAMP-inducible 1 protein are closely related and form a second branch. hPHT1 has 89% identity to rPHT1, while hPHT2 is 81% identical to mouse cAMP-inducible 1 protein. Multiple sequence alignments are provided in Figure 3 , including either the PHT branch only (3A), or both branches (3B). Hydropathy analysis corroborates the close similarity within the PHT and PepT1 branches of the POT family Figure 4A . These hydropathy profiles predict the presence of 11-12 transmembrane domains, as reported earlier. Topological predictions are shown in Figure 4B for hPHT1 and hPHT2.
After completion of this work, a cDNA sequence nearly identical to hPHT2 was deposited by K. Ishiabshi and M. Imai: AB020598, Homo sapiens mRNA for peptide transporter 3, complete cds, 2113 bps in length. This defines the 3' and 5' ends of hPHT1 as having a coding sequence of 1740 bps. The deduced putative cDNA coding sequence is the identical length of the coding sequence suggested by our genomic hPHT2 sequence, and it is identical to hPHT2 over a large portion of the presumed coding region. However, there are also several remarkable differences. First, a fragment of 50 bps in the hPHT2 coding region from position 61-110 is replaced in the cloned cDNA by a 50-bp fragment of low complexity (cg-rich), which is excluded from BLAST analysis by a low complexity filter. This 50-bp cDNA fragment did not recognize any sequence in the PAC clone containing the hPHT2 genomic sequence, but it did recognize fragments in a number of unrelated genes, therefore, possibly representing a low complexity repeat fragment. The remainder of the cDNA sequence was identical to that of hPHT2, except for an insertion of three nucleotides each in three different locations of hPHT2 (at positions 837, 1271, and 1428 of hPHT2). These sequence variations would indicate the presence of three additional amino acids at these respective positions, without disturbing the overall reading frame. It remains to be seen how these changes from our deduced coding sequence came about and whether they are of functional significance. In any case, comparing the cDNA and genomic sequences reveals many details of the possible protein structure not available otherwise.
RT-PCR and Northern Blot Analysis of hPHT1 and hPHT2 mRNA From Human Tissues
The presence of numerous ESTs from many tissues representing the presumed hPHT1 in the databases suggested that hPHT1 might be expressed in many human tissues. RT-PCR analysis had revealed detectable expression of hPHT1 in each of three tissues tested: intestines, skeletal muscle, and pancreas (for intestines, see Figure 5A ). In each of these tissues, the presence of a shorter band suggested a possible splice isoform. The experimentally determined sequence Figure 1B shows a deletion of 169 bases.
For Northern analysis we used two ESTs representing hPHT1 and 2, which were labeled to detect the presence of mRNA in 12 human tissues Figure 5B . hPHT1 was mainly expressed in skeletal muscle, followed by kidney, heart, and liver, with relatively little expression in colon and brain. mRNA bands were detected at apparent molecular weight 2.8 kb and 5.1 kb, indicating the presence of possible mRNA variants.
The mRNA tissue distribution of hPHT2 differed significantly from that of hPHT1 Figure 5B . A single major band appeared at 2.4 kb, with highest expression in spleen, placenta, lung, and leukocytes, followed by heart, kidney, and liver. 
DISCUSSION
This study identifies several new putative members of the POT gene family, using a bioinformatics analysis of available sequence databases, including the human EST database. Because the POT family seemingly stands separate from other transporter gene families, searching for POT-related ESTs is facilitated. With an increasing number of sequences present in the publicly accessible databases, however, we now have begun to find transporters outside the POT gene family with alignment scores that support a finding of possible homology. The INCA search, or any other exhaustive search tool, should be performed periodically to finds the missing links that can document POT's probable homology to other gene families. This will greatly facilitate the study of structure and function of these transporters because one would expect molecular architecture and functional domains to recur in homologous proteins.
In this study, we have used gapped BLAST analyses (19) , which permits inclusion of gaps in local alignments. This carries the possible disadvantage that the permutation matrix used to calculate similarity scores may be inappropriate, in particular for the TMD sections. The use of psi BLAST (19) could overcome this problem by generating a position-specific matrix that would account for mutational drift in TMDs and loops separately. However, our iterative INCA approach could result in overmodeling of the matrix, and thus, possible inclusion of unrelated sequences. Moreover, the primary goal here was to identify new human genes closely related to the known POT family members, rather than probing the most distant relationships.
By far, the largest number of human ESTs aligned best with rPHT1, a peptide-histidine transporter mainly expressed in rat brain. Assembly of numerous ESTs into a contig sequence termed hPHT1 permits a number of observations on the putative coding sequence. More than 95% of the coding sequence expected from comparison to rPHT1 can be derived from the assembled ESTs. In several regions of the deduced hPHT1 sequence, multiple ESTs overlap, thereby providing a first glimpse of possible sequence variations in the human population. While EST sequencing is not rigorously quality controlled and single nucleotide variants occur only sporadically, multiple overlapping ESTs could nevertheless assist in finding single nucleotide polymorphisms (SNPs). There are several such candidate SNPs in the EST alignments: future work will determine whether these do, indeed, represent human sequence variations. However, the presence of possible splice variants of hPHT1 was clearly indicated by an insert or gap in two regions of the hPHT1 coding region. These were detected either by EST alignemnts or experimentally by RT-PCR Figure 1B and Figure 5A . It will be of interest to determine the tissue expression and function of the splice variants. The insert into the loop between TMDs 11 and 12 introduces an additional 100 residue-sequence fragment into hPHT1. This region contains no homology to any other known protein.
A possible splice variant has previously been detected for hPepT1. Inue and colleagues (25) have cloned a cDNA from human duodenum with 1704 bp, encoding a predicted protein of only 208 residues (hPepT1-RF). Of these, residues 18-195 are identical to an equivalent region of hPepT1. This truncated hPepT1 protein appears to lack ability to transport peptides; however, cotransfection of hPepT1-RF with hPepT1 affected the pH sensitivity of peptide transport by hPepT1, suggesting a regulatory function for hPepT1-RF of yet unknown mechanism. The functions of splice variants of hPHT1 remain to be determined.
Assembly of ESTs into a second contig sequence revealed high identity to the mouse cAMP-inducible 1 protein, which was isolated from lymphocytes as one of the upregulated mRNAs after stimulating with cAMP (26) . Close similarity to PHT1 suggests that this gene also encodes a peptide transporter. Using this human contig sequence, we have identified a full-length genomic sequence in a PAC clone from which introns and exons can be predicted for the presumed hPHT2 gene. High identity to the entire mouse cAMP-inducible 1 protein suggests that hPHT2 is the human orthologue, closely related to the PHT-like branch of the POT family. This will facilitate the cloning and testing of this putative new member of the human POT family.
Our comprehensive INCA search uncovered several additional ESTs with sequences similar to members of the POT family. Using BLAST analyses with these ESTs as the query suggested the possibility of additional human POT genes. Further work is needed to complete the human POT family. Also, we cannot preclude that the proposed hPHT 1 and 2 genes, although highly similar to genes encoding rPHT1 and cyclic AMP-inducible 1 protein, are not the immediate orthologues, but that there are as yet additional closely related human genes not represented in the EST database.
The strong representation of hPHT1 in the EST database suggests that the presumed hPHT1 is widely expressed in human tissues, largely in the CNS, in contrast to its restricted expression in rats. One of these ESTs stems from a human colon carcinoma, an indication that hPHT1 may also be expressed in human intestines. We have corroborated this supposition with the use of RT-PCR; however, Northern blot analysis has revealed that hPHT1 and hPHT2 are not highly expressed in intestines relative to other tissues. Protein expression and functional studies are required to determine whether these transporters, in addition to hPepT1, could play a role in intestinal peptoid drug absorption. This could be of considerable pharmacological interest, as previous studies have suggested that PepT1 was the sole peptide transporter in rodent intestines, whereas no definitive experimental evidence has been reported on the responsible transporter subtype in humans. Bioavailability studies demonstrate that peptoid drugs, such as certain antibiotics, largely depend on intestinal absorption by peptide transporters to enter the systemic circulation. For example, coadministration of a dipeptide reduced the oral bioavailability of amoxicillin by 80% in human subjects providing strong evidence that a saturable dipeptide transport process is involved (27) . Whether hPHT1 or 2 could play a role in oral antibiotic bioavailability remains to be seen.
Our Northern blot analysis revealed strong expression for hPHT1 in skeletal muscle and kidney while hPHT2 was highly expressed in leukocytes, lung placenta, and spleen. Detectable expression of both genes in organs, such as the heart, may be of interest in understanding the efficacy of antibiotic treatment of localized infections -; particularly if the infectious agent resides intracellularly. The tissue distribution of gene expression differs from that of hPepT1 (mainly intestinal) and hPepT2 (mainly renal) which underscores the relevance of our findings to targeting therapy to specific organs. It is curious to note that neither hPHT1 nor hPHT2 are strongly expressed in the brain, while rPHT1 is highly expressed in the CNS. It will be of interest to establish the role of any peptide transporters expressed in human brain.
Overall, our results indicate that the human POT family contains at least 4 genes encoding possible peptide transporters. Each displays a distinct pattern of tissue expression, providing a possible avenue for drug targeting to select tissues. Tissue distribution of POT gene expression is of particular interest for achieving oral bioavailability or targeting drugs to tumor tissues. For example, Tsuji et al have identified a fibrosarcoma cell line expressing an unusual H + /dipeptide transporter activity (17) . We have determined that hPepT1 is highly expressed in pancreatic (28) and colon adenocarcinomas, including liver metastases (M.Y. Covitz and W.S., unpublished data), considerably above the level seen in surrounding normal tissues. Moreover, each member of the peptide transporter family is likely to exhibit distinct selectivities for peptides and peptoid drugs. Thus, amino acid esters of 5'nucleosides (eg, valcyclovir) (15) are recognized by hPepT1, even though the structure of these prodrugs is quite distinct from dipeptides. However, affinity of these nucleoside prodrugs for other peptide transporters remains to be determined. One could envisage a large variety of amino acid-nucleoside prodrugs of antivirals or anticancer agents to enhance oral bioavailability or target the drug to tumor tissues, as a function of which peptide transporter is expressed in the target tissue. Phenotypic characterization of tumor tissues as to which transporters are expressed and to what extent will become an important question that extends beyond the peptide transporter family, and indeed should be applied to all known drug transporters.
